¡i´î­«±M¿è¡j´îªÎÃħO¶Ã¦Y¡I¦Xªk´îªÎÃÄ¥u¦³3Ãþ¡@Âå®v´£¿ô´îªÎ²£«~9ª`·N¨Æ¶µ

2023-06-16 1571

¦pªG¦³®³¨ìÃÄÃÒ¤S¨S¦³ÃÄ«~¥é³æ¼Ð¥Ü¥~¨Ï¥Î¡]Off-Label Use¡^ªº¸Ü¡A¤j·§¥i¥H¤À¬°3¤jÃþ´îªÎÃĪ«¡C

´îªÎÅܽG¬O³\¦h¤Hªº¥Ø¼Ð¡A¦³¨Ç¤H·Q¾aÃĪ«¡B¤â³Nµ¥¶i¦æ´î­«¡C¦ý¥«­±¤W¦³¦U¦¡¦U¼Ëªº´îªÎÃÄ¡A¤]¦³³\¦h«O°·­¹«~«ÅºÙ¦³´îªÎ®ÄªG¡A¨ì©³¦³­þ¨Ç¬O¦Xªkªº¡H¤S­n²Å¦X­þ¨Ç±ø¥ó¡AÂå®v¤~·|«Øij¨Ï¥Î©O¡H»O¥_Âå°|°Æ°|ªøº[Åé­«ºÞ²z¤¤¤ß¥~¬ìÂå®v¼Ú«G§»¨Ó¸Ñµª¡I

3¤jÃþ¦Xªk´îªÎÃÄ¡@±Æ¯×¡B§í¨î­¹¼¤

©Ò¿×ªº¡u¦Xªk´îªÎÃÄ¡v¬O¤°»ò¡H¼Ú«G§»°Æ°|ªøªí¥Ü¡A³o²o§è¨ì¦³¨S¦³½ÃºÖ³¡©Î°ê¥~­¹«~ÃĪ«ºÞ²z§½¡]¦p¡GFDA¡^ªº³\¥i¡A¦pªG¦³®³¨ìÃÄÃÒ¤S¨S¦³¡uÃÄ«~¥é³æ¼Ð¥Ü¥~¨Ï¥Î¡]Off-Label Use¡^¡vªº¸Ü¡A¤j·§¥i¥H¤À¬°¥H¤U3¤jÃþ´îªÎÃĪ«¡G

1.±Æ¯×ÃÄ¡G
§í¨î¤p¸z¤ºªº¯×ªÕ酶¡AÅý¯×ªÕ¦b¤p¸z¤¤¤£®e©öÅܦ¨¤p¤À¤l¡A¨Ï¯×ªÕ¸û¤£·|³Q§l¦¬¡C¦Xªk±Æ¯×ÃþÃĪ«¥]§tOrlistat¡Bù¤óÂAXenicalµ¥¡C

¼Ú«G§»°Æ°|ªø´£¨ì¡A¦³ªÎ­D°ÝÃD¤S¦³«K¯µ±¡§Îªº¯f¤H«D±`¾A¦X¨Ï¥Î¡A¦]¬°¥¦¦³§Q«K¡B±Æ«K§@¥Î¡A¤£¹L¥²¶·­nª`·N¡A¦pªGªA¥Î¹L¶q©Îªø´Á¨Ï¥Î¡A¯×·»©Êºû¥Í¯À·|µLªk§l¦¬¡A³y¦¨¯×·»©Êºû¥Í¯ÀA¡BD¡BE¡BK¯Ê¥F¡C

2.¸zªc¯ÀÃþ¦üÃÄ¡]GLP-1 agonist¡^¡G
·í¤H¶i­¹«á¡A¤p¸z·|¤Àªc¸zªc¯À¡A¨ä¤¤¤@ºØ¸zªc¯À´N¬OGLP-1¡A¥i¥H­°§C­G±ÆªÅ³t«×¡B§í¨î­¹¼¤µ¥¡C¦Ó¸zªc¯ÀÃþ¦üÃÄ¡A´N¬O¤@­ÓÃþ¦ü¸z­G²üº¸»XªºÃĪ«¡A¥i¥H²£¥Í§@¥Î§í¨î­¹¼¤¡AÅý¸z­G¹Dı±o¤w¸g¦³¨¬°÷ªº­¹ª«¡C

³oÃþÃĪ«¥»¨Ó¬O¦b·s³¯¥NÁ¬ì¡A¨Ï¥Î¦b²Ä¤G«¬¿}§¿¯f±±¨î¦å¿}ªº¤@ºØÃÄ«~¡C¥Ø«e¦³¤fªA¡B°w¾¯¡A¦Ó°w¾¯´N¬O²{¦b«UºÙªº¡u½G½G°w¡v¡C¦Xªk¸zªc¯ÀÃþ¦üÃÄ¥]§t·ç­¿¾ASemaglutide¡Bµ½ÅÖ¹FLiraglutideµ¥¡C

3.§Ü¼~Æ{¾¯»P§ÙÂ_¯g­Ô¸s½Æ¤èÃÄ¡G
³oÃþ½Æ¤èÃÄ«üªº¬OContrave±dÅ֪ܡA¥»¨Ó¬O¤@­Ó§Ü¼~Æ{¾¯»P§ÙÂ_¯g­Ô¸sªº½Æ¤èÃÄ¡A¦ý¨Ï¥Î³oÃĪ««á¤]¥i¥H§í¨î­¹¼¤¡C

2Ãþ¤H²Å¦X¾AÀ³¯g¡@´îªÎÃĪ«¨Ï¥Î9ª`·N¨Æ¶µ

¥Á²³­Y­n¨Ï¥Î¤W­z¤TÃþÃĪ«¶i¦æ´î­«¡AÂå®v·|®Ú¾Ú½ÃºÖ³¡´£¨Ñªº¾AÀ³¯g¡A¨Ã¤F¸Ñ¯f¤HªºÅ髬¡BÅé­«¡B¥Í¬¡«¬ºAµ¥¡A¸g¹Lµû¦ô«á¤~·|«Øij¨Ï¥ÎÃĪ«¡C¼Ú«G§»°Æ°|ªø«ü¥X¡A½ÃºÖ³¡´£¨Ñªº¾AÀ³¯g¥]§t¥H¤U2±ø¥ó¡G

1.¨­Åé½è¶q«ü¼Æ¡]BMI¡^¤j©ó30

2.BMI¤j©ó27¥B¦X¨Ö¥NÁ¯g­Ô¸s¡B°ª¦å¿}¡B°ª¦åÀ£¡B°ª¦å¯×µ¥¥NÁ°ÝÃD

¤£¹L¡A´îªÎÃÄÁöµM¦Y¤F·|¦³®ÄªG¡A¦ý¤´­nª`·N¶¼­¹¡B¹B°Ê¡A¦Ó¥BÃĪ«ªº¨ú±o³~®|¤]­nª`·N¡A¤×¨ä²{¦b¥«­±¤W«Ü¦h«O°·«~«ÅºÙ¦³´îªÎ®ÄªG¡A¦b³o¨Ç²£«~¡BÃÄ«~ªº¨Ï¥Î¤W¡A¼Ú«G§»°Æ°|ªø´£¿ô¥H¤Uª`·N¨Æ¶µ¡G

•¦Xªk´îªÎÃÄ«~¶·¸g¹LÂå®v³B¤è¡AÃħ½¤£·|³c°â

•Ãħ½³c°âªº´î­«¿U¯×²£«~¡A°ò¥»¤W³£Äݩ󭹫~Ãþ¡A´îªÎ«O°·­¹«~¥u­n¸g­¹Ãĸp¡B½Ã¥Í§½µ¥»{¥i´N¥i¤W¥«¨Ï¥Î¡A¦ý®ÄªG¡B°Æ§@¥Îµ¥³£¦³«Ý°Óºe

•¦³¨Ç°Ó«~°ÑÂø¤¤ÃĦ¨¤À¡A³o¨Ç½Æ¤èÃĨϥΤW­n®æ¥~¤p¤ß¡A¶·¸ß°ÝÃÄ®v

•¨Ï¥Î¤@¯ëÃĪ«¡]¦p¡G¥Òª¬¸¢¯À¡B§Ü§Q§¿¾¯¡^ªº°Æ§@¥Î¨Ó±±¨îÅé­«¨Ã¤£¦n¡Aµu´Á®ÄªGÁöµM©úÅã¡A¦ýªø´Á¨Ó»¡¨ä¹ê¹ï¨­Åé¬OºØºC©Ê¶Ë®`

•¥ô¦óÃĪ«¼Ð¥Ü³£­n²M·¡¡A¥B¨Ï¥Î®É³£­n¤F¸ÑÃĪ«¨ú±o³~®|¡BÃĪ«§@¥Î¡B°Æ§@¥Îµ¥

•3Ãþ¦Xªk´îªÎÃĪ«³£ÄÝ©ó¦Û¶OÃĪ«¡AµL°·«Oµ¹¥I

•3Ãþ¦Xªk´îªÎÃĪ«¤j³¡¤À­n¨Ï¥Î1¡Ð2­Ó¤ë¥H¤W¤~¦³®ÄªG

•3Ãþ¦Xªk´îªÎÃĪ«³£«Øijµu´Á¨Ï¥Î¡A2¡Ð3­Ó¤ë«á´N­n°±ÃÄ

•°£¤F¨Ï¥ÎÃĪ«¥~¡A¥Í¬¡¡B¶¼­¹³£­n§ïÅÜ¡AÁקK°±ÃÄ«á´_­D

¼Ú«G§»°Æ°|ªøªí¥Ü¡A±`¦³BMI¤j¬ù20ªì¥B¨­§÷¤£¿ùªº¥Á²³¡A´M¨DÅé­«±±¨î¡B´î­«¡A³q±`Âå®v·|«Øij¹B°Ê¡B¶¼­¹©Î¥Í¬¡§@®§½Õ¾ãµ¥¸û°·±d«O¦uªº¼Ò¦¡¡A´`§Çº¥¶i¶i¡A­Y®ÄªG¤£¨Î¤~·|¾A«×¨Ï¥ÎÃĪ«¡C

¦Ó²{¦b³\¦hÂåÀø°|©Ò³£¦³¨ó§UÅé­«±±¨îªº³æ¦ì¡A¥ÑÂå®v¡BÀç¾i®vµ¥²Õ¦¨¡A¼Ú«G§»°Æ°|ªø«Øij¡A¥Á²³­Y¦³¬ÛÃö»Ý¨D¡AÀ³´M¨D±M·~µû¦ô¡A¦A¸g¹LÂå®v³B¤è¨Ï¥ÎÃĪ«¡C

¥»¤å¸g °·±dÂåÀøºô ±ÂÅv¥Zµn¡A­ì¤åµoªí©ó¦¹
¡i°·±dÂåÀøºô¡þ°OªÌ§d»ö¤å³ø¾É¡j2023/06/15

ment,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-35937129-1', 'auto'); ga('send', 'pageview');